FDA Approves Leqembi, a New Alzheimer’s Drug
The FDA approved the new Alzheimer’s drug lecanemab (BAN2401), which will be sold under the brand name Leqembi developed by Eisai and Biogen last week for patients with mild cognitive …
New Alzheimer’s Drug
Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline
A late-stage clinical trial was conducted by Biogen and Eisai and the new Alzheimer’s drug they are developing for Alzheimer’s disease slowed the rate of cognitive decline. New Alzheimer’s Drug …
Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline Read More »
Biogen Seeks FDA Approval for New Alzheimer’s Drug
Biogen is planning to file for U.S. regulatory approval for its Alzheimer’s treatment aducanumab after data from more patients in two discontinued studies showed that the drug improved cognition at …
Biogen Seeks FDA Approval for New Alzheimer’s Drug Read More »